Jennison Associates
BRLI

Jennison Associates’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Jennison Associates’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-181,970
Closed -$4.65M – 813
2013
Q4 		$4.65M Sell
181,970
-1,682,153
-90% -$51.8M ﹤0.01% 509
2013
Q3 		$55.7M Sell
1,864,123
-217,212
-10% -$6.04M 0.06% 279
2013
Q2 		$59.8M Buy
+2,081,335
New +$57.4M 0.07% 261

Other funds holding BRLI

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $24B AUM 39.59% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jennison Associates's BRLI Position: Q1 2014 in Review

Jennison Associates sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q1 2014, closing a stake of 181,970 shares — an estimated $4.65M sold.

Jennison Associates first reported a position in BRLI in Q2 2013 and held it in 3 quarters. The position peaked at $59.8M in Q2 2013. 162 funds tracked by Wall St. Rank hold BRLI as of Q1 2014.

  • Jennison Associates reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q1 2014 after selling out during the quarter.
  • Jennison Associates sold 181,970 BIO-REFERENCE LABS INC-NEW- shares in Q1 2014, an estimated $4.65M.
  • Jennison Associates first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 3 quarters.
  • Jennison Associates's BIO-REFERENCE LABS INC-NEW- position peaked at $59.8M in Q2 2013.
  • 162 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q1 2014.

Based on Jennison Associates's 13F filing for Q1 2014, filed 7 May 2014.